# Methylene Blue Injection for Nonneoplastic Epithelial Disorders of Vulva

> **NCT03200808** · PHASE1 · COMPLETED · sponsor: **Maternal and Child Health Hospital of Hubei Province** · enrollment: 118 (actual)

## Conditions studied

- Nonneoplastic Epithelial Disorders of Vulva

## Interventions

- **DRUG:** mixed methylene blue compound injection

## Key facts

- **NCT ID:** NCT03200808
- **Lead sponsor:** Maternal and Child Health Hospital of Hubei Province
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10-01
- **Primary completion:** 2018-10-01
- **Final completion:** 2019-10-17
- **Target enrollment:** 118 (ACTUAL)
- **Last updated:** 2022-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03200808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03200808, "Methylene Blue Injection for Nonneoplastic Epithelial Disorders of Vulva". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03200808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*